EUROPEAN SURGICAL REGISTRY FOR RARE ENDOCRINE TUMOURS

By collecting and sharing data on performed treatment and medical performance on rare diseases, we can gather knowledge and identify best practice. From there we can learn from each other and advance our methods to the benefit for the patient.

TO THE PROJECT

Interest of participation in the EUROCRINE database

Please register below if you and your clinic have future interest in participation in the Eurocrine database. Signing up does not require any commitments from you. By signing up you will also be updated on the project progress.

 

CLICK TO REGISTER INTEREST

Register for newsletter

If you are interested in how the Eurocrine project is progressing, please sign up for our newsletter. If you later wish to unsuscribe, cancellation can be made by a simple click on a link at the bottom of each newsletter.

 

CLICK TO REGISTER FOR NEWSLETTER

News

The newly released module, My Eurocrine,is a novel feature to the database, which provides the user with additional unique flexibility to tailor the database to local needs. With this new feature you can create your own variables for collection of data,... Read more

The Eurocrine registry reached 1 000 registered operations in the start of 2016, and have now passed 1 500 operations. There is still time for participation in the first analysis - if your clinic start now. 24 clinics from 12 countries are participating with data.

The collection of data has started on all diagnoses groups: thyroid, primary and secondary hyperparathyroidism, paraganglioma, adrenal tumours, and GEP-NET. The following working languages are available: English, French, German, Italian, Polish, Spanish, and Turkish.... Read more

Identify best practice – Compiled data makes it possible to compare effectiveness in preoperative work-up, operation, surgical treatment, and outcome.

Benchmark yourself – Compare your outcome data with that of your country and... Read more

The work on the physical registry has been ongoing since August. The included disease modules for Thyroid, Parathyroid, Adrenal, Paraganglioma, and Neuroendocrine Tumours in the gastrointestinal tract (GEP-NET) have been developed, and are being β-tested by partners.... Read more

Associated partners

ESES
JUMC
AFCE
BSES